* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Buspirone - Tehran University of Medical Sciences
Cannabinoid receptor antagonist wikipedia , lookup
Nicotinic agonist wikipedia , lookup
Environmental impact of pharmaceuticals and personal care products wikipedia , lookup
Pharmacogenomics wikipedia , lookup
Neuropharmacology wikipedia , lookup
Polysubstance dependence wikipedia , lookup
Psychopharmacology wikipedia , lookup
Dydrogesterone wikipedia , lookup
Ghyasvand, M.D. Roozbeh Hospital, TUMS 2013 Full agonist for presynaptic 5-HT1A receptors Partial agonist for postsynaptic 5-HT1A r. Weak antagonist for 5-HT2C r. Agonist& antagonist for D2 r. Buspirone (buspar): tab 5&10 mg Absorption is delayed by food ingestion. Because of a short half-life (2 to 11 hours), buspirone is dosed three times daily. Buspirone takes 2 to 3 weeks to exert its therapeutic effects. Buspirone is a narrow-spectrum antianxiety agent, with demonstrated efficacy only in the treatment of generalized anxiety disorder. Buspirone does not cause weight gain, sexual dysfunction, discontinuation symptoms, or significant sleep disturbance. It does not produce sedation or cognitive and psychomotor impairment. The most common adverse effects of buspirone are headache, nausea, dizziness, and, rarely, insomnia. Buspirone should be used with caution by persons with hepatic and renal impairment. Pregnancy: group B Breast feeding: L3 Treatment is usually initiated with either 5 mg orally three times daily or 7.5 mg orally twice daily. The dosage can be raised 5 mg every 2 to 4 days to the usual dosage range of 15 to 60 mg a day. The two alternatives are as follows: First, the clinician can start buspirone treatment gradually while the benzodiazepine is being withdrawn. Second, the clinician can start buspirone treatment and bring the person up to a therapeutic dosage for 2 to 3 weeks, while the person is still receiving the regular dosage of the benzodiazepine, and then slowly taper the benzodiazepine dosage. Patients who have received benzodiazepines in the past, especially in recent months, may find that buspirone is not as effective as the benzodiazepines in treating their anxiety. This might be explained by the absence of the immediate mildly euphoric and sedative effects of the benzodiazepines. The coadministration of buspirone and benzodiazepines may be effective in the treatment of anxiety disorders that have not responded to treatment with either drug alone. Any Question?